Literature DB >> 26807173

Loss of miR-532-5p in vitro promotes cell proliferation and metastasis by influencing CXCL2 expression in HCC.

Xiaofei Song1, Zie Wang1, Yan Jin1, Yong Wang1, Wenbing Duan1.   

Abstract

MicroRNAs (miRNAs) have been widely reported, which play important roles in cancer development. CXCL2 acts as an oncogene, however, its regulation by miRNAs is not clear in hepatocellular carcinoma (HCC). In our research, it is aimed to study the role of CXCL2 in HCC and the regulation of its expression by miRNAs. Firstly, we found that CXCL2 was up-regulated in the blood of patients with HCC and cell lines compared with the normal controls. CXCL2 could enhance HCC cell proliferation and metastasis. miR-532-5p was predicted as a regulatory miRNA of CXCL2 in HCC, and negatively associated with CXCL2 in HCC samples. It was also verified that miR-532-5p inhibited cell proliferation and metastasis of HCC cells by inhibition CXCL2. Collectively, our findings suggested that miR-532-5p may function as a tumor suppressor in HCC by targeting CXCL2.

Entities:  

Keywords:  CXCL2; HCC; cell proliferation; metastasis; miR-532-5p

Year:  2015        PMID: 26807173      PMCID: PMC4697705     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  18 in total

Review 1.  Pathogenesis and prognosis of hepatocellular carcinoma at the cellular and molecular levels.

Authors:  Olivier Govaere; Tania Roskams
Journal:  Clin Liver Dis       Date:  2015-03-03       Impact factor: 6.126

2.  Identification of circulating microRNAs as potential biomarkers for detecting acute ischemic stroke.

Authors:  Pengfei Li; Fengmeng Teng; Feng Gao; Mingshun Zhang; Jinping Wu; Chunbing Zhang
Journal:  Cell Mol Neurobiol       Date:  2014-11-20       Impact factor: 5.046

3.  MicroRNA profiling in chemoresistant and chemosensitive acute myeloid leukemia.

Authors:  N Mosakhani; R Räty; A Tyybäkinoja; M-L Karjalainen-Lindsberg; E Elonen; S Knuutila
Journal:  Cytogenet Genome Res       Date:  2013-05-16       Impact factor: 1.636

4.  miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2.

Authors:  Emanuel Kronski; Micol E Fiori; Ottavia Barbieri; Simonetta Astigiano; Valentina Mirisola; Peter H Killian; Antonino Bruno; Arianna Pagani; Francesca Rovera; Ulrich Pfeffer; Christian P Sommerhoff; Douglas M Noonan; Andreas G Nerlich; Laura Fontana; Beatrice E Bachmeier
Journal:  Mol Oncol       Date:  2014-01-16       Impact factor: 6.603

Review 5.  Peripheral blood stem cell mobilization: the CXCR2 ligand GRObeta rapidly mobilizes hematopoietic stem cells with enhanced engraftment properties.

Authors:  Louis M Pelus; Seiji Fukuda
Journal:  Exp Hematol       Date:  2006-08       Impact factor: 3.084

6.  Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2.

Authors:  Peter H Killian; Emanuel Kronski; Katharina M Michalik; Ottavia Barbieri; Simonetta Astigiano; Christian P Sommerhoff; Ulrich Pfeffer; Andreas G Nerlich; Beatrice E Bachmeier
Journal:  Carcinogenesis       Date:  2012-10-05       Impact factor: 4.944

7.  CCL2 in chronic lymphocytic leukemia: a macro in microenvironment?

Authors:  Varsha Gandhi; Kumudha Balakrishnan
Journal:  Leuk Lymphoma       Date:  2012-05-21

8.  Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.

Authors:  Minoru Kitago; Steve R Martinez; Takeshi Nakamura; Myung-Shin Sim; Dave S B Hoon
Journal:  Clin Cancer Res       Date:  2009-03-31       Impact factor: 12.531

9.  MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features.

Authors:  Heejeong Lee; Chul Soo Park; Georgios Deftereos; Janice Morihara; Joshua E Stern; Stephen E Hawes; Elizabeth Swisher; Nancy B Kiviat; Qinghua Feng
Journal:  World J Surg Oncol       Date:  2012-08-27       Impact factor: 2.754

10.  Hepatocellular proliferation correlates with inflammatory cell and cytokine changes in a murine model of nonalchoholic fatty liver disease.

Authors:  Michael N Vansaun; Alisha M Mendonsa; D Lee Gorden
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

View more
  26 in total

1.  MiR-217 promotes cutaneous squamous cell carcinoma progression by targeting PTRF.

Authors:  Ming Bai; Mingzi Zhang; Fei Long; Nanze Yu; Ang Zeng; Xiaojun Wang
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

2.  MicroRNA-532 exerts oncogenic functions in t(4;14) multiple myeloma by targeting CAMK2N1.

Authors:  Kaihong Xu; Xuezhen Hu; Laifang Sun; Qingyue Liang; Guifang Ouyang; Yanli Zhang; Qitian Mu; Xiao Yan
Journal:  Hum Cell       Date:  2019-08-26       Impact factor: 4.174

3.  A genetic variant located in the miR-532-5p-binding site of TGFBR1 is associated with the colorectal cancer risk.

Authors:  Dongying Gu; Shuwei Li; Mulong Du; Cuiju Tang; Haiyan Chu; Na Tong; Zhengdong Zhang; Meilin Wang; Jinfei Chen
Journal:  J Gastroenterol       Date:  2018-07-03       Impact factor: 7.527

4.  MicroRNA-144 inhibits hepatocellular carcinoma cell proliferation, invasion and migration by targeting ZFX.

Authors:  Hongbin Bao; Xinguo Li; Hengli Li; Hongli Xing; Binghui Xu; Xianfeng Zhang; Zhaoming Liu
Journal:  J Biosci       Date:  2017-03       Impact factor: 1.826

5.  MiR-384 regulated IRS1 expression and suppressed cell proliferation of human hepatocellular carcinoma.

Authors:  Yue-Yuan Lai; Fei Shen; Wen-Song Cai; Ji-Wei Chen; Jian-Hua Feng; Jie Cao; Huan-Qing Xiao; Guang-Hui Zhu; Bo Xu
Journal:  Tumour Biol       Date:  2016-08-19

6.  microRNA-532 suppresses the PI3K/Akt signaling pathway to inhibit colorectal cancer progression by directly targeting IGF-1R.

Authors:  Ying Song; Yue Zhao; Xiangfu Ding; Xiaodong Wang
Journal:  Am J Cancer Res       Date:  2018-03-01       Impact factor: 6.166

7.  Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells.

Authors:  Jun Lu; Wei Xu; Jie Qian; Shuyuan Wang; Bo Zhang; Lele Zhang; Rong Qiao; Minjuan Hu; Yiming Zhao; Xiaodong Zhao; Baohui Han
Journal:  BMC Med Genomics       Date:  2019-03-13       Impact factor: 3.063

8.  MicroRNA-532 protects the heart in acute myocardial infarction, and represses prss23, a positive regulator of endothelial-to-mesenchymal transition.

Authors:  Ahmed S Bayoumi; Jian-Peng Teoh; Tatsuya Aonuma; Zhize Yuan; Xiaofen Ruan; Yaoliang Tang; Huabo Su; Neal L Weintraub; Il-Man Kim
Journal:  Cardiovasc Res       Date:  2017-11-01       Impact factor: 10.787

9.  miRNA and long non-coding RNA transcriptional expression in hepatocellular carcinoma cell line-secreted extracellular vesicles.

Authors:  Manuela Cabiati; Costanza Salvadori; Giuseppina Basta; Serena Del Turco; Paolo Aretini; Antonella Cecchettini; Silvia Del Ry
Journal:  Clin Exp Med       Date:  2021-07-28       Impact factor: 3.984

10.  Collaboration of cancer-associated fibroblasts and tumour-associated macrophages for neuroblastoma development.

Authors:  Okito Hashimoto; Makiko Yoshida; Yu-Ichiro Koma; Tomoko Yanai; Daiichiro Hasegawa; Yoshiyuki Kosaka; Noriyuki Nishimura; Hiroshi Yokozaki
Journal:  J Pathol       Date:  2016-09-19       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.